|AI Robots Name||P/L||Entry Price, $||Profit, $/%|
|AI Robots Name||P/L||Entry Price, $||Profit, $/%|
The 10-day moving average for IQV crossed bearishly below the 50-day moving average on February 28, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 64%.
The Momentum Indicator moved below the 0 level on March 09, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on IQV as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
IQV moved below its 50-day moving average on March 07, 2023 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IQV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for IQV entered a downward trend on March 23, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IQV's RSI Oscillator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IQV advanced for three days, in of 352 cases, the price rose further within the following month. The odds of a continued upward trend are .
IQV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IQV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.072) is normal, around the industry mean (16.026). P/E Ratio (32.895) is within average values for comparable stocks, (182.825). Projected Growth (PEG Ratio) (1.349) is also within normal values, averaging (5.799). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (2.487) is also within normal values, averaging (59.834).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of biopharmaceutical development services and commercial outsourcing services
A.I.dvisor indicates that over the last year, IQV has been closely correlated with ICLR. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then ICLR could also see price increases.
|ICLR - IQV|
|TMO - IQV|
|MTD - IQV|
|DHR - IQV|
|PKI - IQV|